These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32546831)

  • 1. Frequency of genomic secondary findings among 21,915 eMERGE network participants.
    eMERGE Clinical Annotation Working Group
    Genet Med; 2020 Sep; 22(9):1470-1477. PubMed ID: 32546831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actionable secondary findings following exome sequencing of 836 non-obstructive azoospermia cases and their value in patient management.
    Kasak L; Lillepea K; Nagirnaja L; Aston KI; Schlegel PN; Gonçalves J; Carvalho F; Moreno-Mendoza D; Almstrup K; Eisenberg ML; Jarvi KA; O'Bryan MK; Lopes AM; Conrad DF; ; Punab M; Laan M
    Hum Reprod; 2022 Jun; 37(7):1652-1663. PubMed ID: 35535697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of actionable secondary findings in 7472 Korean genomes derived from the National Project of Bio Big Data pilot study.
    Kim Y; Kim JM; Cho HW; Park HY; Park MH
    Hum Genet; 2023 Nov; 142(11):1561-1569. PubMed ID: 37728764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review.
    Elfatih A; Mohammed I; Abdelrahman D; Mifsud B
    Physiol Genomics; 2021 Sep; 53(9):373-384. PubMed ID: 34250816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.
    Hart MR; Biesecker BB; Blout CL; Christensen KD; Amendola LM; Bergstrom KL; Biswas S; Bowling KM; Brothers KB; Conlin LK; Cooper GM; Dulik MC; East KM; Everett JN; Finnila CR; Ghazani AA; Gilmore MJ; Goddard KAB; Jarvik GP; Johnston JJ; Kauffman TL; Kelley WV; Krier JB; Lewis KL; McGuire AL; McMullen C; Ou J; Plon SE; Rehm HL; Richards CS; Romasko EJ; Miren Sagardia A; Spinner NB; Thompson ML; Turbitt E; Vassy JL; Wilfond BS; Veenstra DL; Berg JS; Green RC; Biesecker LG; Hindorff LA
    Genet Med; 2019 May; 21(5):1100-1110. PubMed ID: 30287922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actionable exomic incidental findings in 6503 participants: challenges of variant classification.
    Amendola LM; Dorschner MO; Robertson PD; Salama JS; Hart R; Shirts BH; Murray ML; Tokita MJ; Gallego CJ; Kim DS; Bennett JT; Crosslin DR; Ranchalis J; Jones KL; Rosenthal EA; Jarvik ER; Itsara A; Turner EH; Herman DS; Schleit J; Burt A; Jamal SM; Abrudan JL; Johnson AD; Conlin LK; Dulik MC; Santani A; Metterville DR; Kelly M; Foreman AK; Lee K; Taylor KD; Guo X; Crooks K; Kiedrowski LA; Raffel LJ; Gordon O; Machini K; Desnick RJ; Biesecker LG; Lubitz SA; Mulchandani S; Cooper GM; Joffe S; Richards CS; Yang Y; Rotter JI; Rich SS; O'Donnell CJ; Berg JS; Spinner NB; Evans JP; Fullerton SM; Leppig KA; Bennett RL; Bird T; Sybert VP; Grady WM; Tabor HK; Kim JH; Bamshad MJ; Wilfond B; Motulsky AG; Scott CR; Pritchard CC; Walsh TD; Burke W; Raskind WH; Byers P; Hisama FM; Rehm H; Nickerson DA; Jarvik GP
    Genome Res; 2015 Mar; 25(3):305-15. PubMed ID: 25637381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raising Genomic Citizens: Adolescents and the Return of Secondary Genomic Findings.
    Sabatello M; Appelbaum PS
    J Law Med Ethics; 2016 Jun; 44(2):292-308. PubMed ID: 27338605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.
    Berg JS; Amendola LM; Eng C; Van Allen E; Gray SW; Wagle N; Rehm HL; DeChene ET; Dulik MC; Hisama FM; Burke W; Spinner NB; Garraway L; Green RC; Plon S; Evans JP; Jarvik GP;
    Genet Med; 2013 Nov; 15(11):860-7. PubMed ID: 24195999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary actionable findings identified by exome sequencing: expected impact on the organisation of care from the study of 700 consecutive tests.
    Thauvin-Robinet C; Thevenon J; Nambot S; Delanne J; Kuentz P; Bruel AL; Chassagne A; Cretin E; Pelissier A; Peyron C; Gautier E; Lehalle D; Jean-Marçais N; Callier P; Mosca-Boidron AL; Vitobello A; Sorlin A; Tran Mau-Them F; Philippe C; Vabres P; Demougeot L; Poé C; Jouan T; Chevarin M; Lefebvre M; Bardou M; Tisserant E; Luu M; Binquet C; Deleuze JF; Verstuyft C; Duffourd Y; Faivre L
    Eur J Hum Genet; 2019 Aug; 27(8):1197-1214. PubMed ID: 31019283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary genomic findings in the 2020 China Neonatal Genomes Project participants.
    Xiao H; Zhang JT; Dong XR; Lu YL; Wu BB; Wang HJ; Zhao ZY; Yang L; Zhou WH
    World J Pediatr; 2022 Oct; 18(10):687-694. PubMed ID: 35727495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
    Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT
    Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients.
    Horiuchi Y; Matsubayashi H; Kiyozumi Y; Nishimura S; Higashigawa S; Kado N; Nagashima T; Mizuguchi M; Ohnami S; Arai M; Urakami K; Kusuhara M; Yamaguchi K
    Hum Genet; 2021 Feb; 140(2):321-331. PubMed ID: 32710294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actionable secondary findings in 1116 Hong Kong Chinese based on exome sequencing data.
    Yu MHC; Mak CCY; Fung JLF; Lee M; Tsang MHY; Chau JFT; Chung PH; Yang W; Chan GCF; Lee SL; Lau YL; Tam PKH; Tang CSM; Yeung KS; Chung BHY
    J Hum Genet; 2021 Jun; 66(6):637-641. PubMed ID: 33223521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study.
    Haverfield EV; Esplin ED; Aguilar SJ; Hatchell KE; Ormond KE; Hanson-Kahn A; Atwal PS; Macklin-Mantia S; Hines S; Sak CW; Tucker S; Bleyl SB; Hulick PJ; Gordon OK; Velsher L; Gu JYJ; Weissman SM; Kruisselbrink T; Abel C; Kettles M; Slavotinek A; Mendelsohn BA; Green RC; Aradhya S; Nussbaum RL
    BMC Med; 2021 Aug; 19(1):199. PubMed ID: 34404389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Return of non-ACMG recommended incidental genetic findings to pediatric patients: considerations and opportunities from experiences in genomic sequencing.
    Bowling KM; Thompson ML; Kelly MA; Scollon S; Slavotinek AM; Powell BC; Kirmse BM; Hendon LG; Brothers KB; Korf BR; Cooper GM; Greally JM; Hurst ACE
    Genome Med; 2022 Nov; 14(1):131. PubMed ID: 36414972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric manifestations of rare variation in medically actionable genes: a PheWAS approach.
    Feng YA; Stanaway IB; Connolly JJ; Denny JC; Luo Y; Weng C; Wei WQ; Weiss ST; Karlson EW; Smoller JW
    BMC Genomics; 2022 May; 23(1):385. PubMed ID: 35590255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-frequency actionable pathogenic exome variants in an average-risk cohort.
    Rego S; Dagan-Rosenfeld O; Zhou W; Sailani MR; Limcaoco P; Colbert E; Avina M; Wheeler J; Craig C; Salins D; Röst HL; Dunn J; McLaughlin T; Steinmetz LM; Bernstein JA; Snyder MP
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30487145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes.
    Jang MA; Lee SH; Kim N; Ki CS
    Genet Med; 2015 Dec; 17(12):1007-11. PubMed ID: 25856671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary findings in a large Pakistani cohort tested with whole genome sequencing.
    Skrahin A; Cheema HA; Hussain M; Rana NN; Rehman KU; Kumar R; Oprea G; Ameziane N; Rolfs A; Skrahina V
    Life Sci Alliance; 2023 Mar; 6(3):. PubMed ID: 36635046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic literature review of disclosure practices and reported outcomes for medically actionable genomic secondary findings.
    Sapp JC; Facio FM; Cooper D; Lewis KL; Modlin E; van der Wees P; Biesecker LG
    Genet Med; 2021 Dec; 23(12):2260-2269. PubMed ID: 34433902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.